The effect of salt on renal damage in eNOS-deficient mice

Hypertension Research

Volumn 33, Issue 2, 2010, Pages 170-176

  Daumerie, Geraldine ^a   Bridges, Lakeesha ^b   Yancey, Sadiqa ^b   Davis, Wendell ^c   Huang, Paul ^d   Loscalzo, Joseph ^e   Pointer, Mildred A ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^c UNIVERSITY OF NEW HAMPSHIRE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Blood pressure; Kidney; Nitric oxide synthase; Renal fibrosis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; ENZYME DEFICIENCY; GLOMERULUS; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOPATHOLOGY; HYPERTENSION; INFLAMMATION; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY MASS; KIDNEY TUBULE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERIVASCULAR INFLAMMATION; SALT INTAKE; SYSTOLIC BLOOD PRESSURE; THROMBOSIS; WILD TYPE;

AFRICAN AMERICANS; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; HUMANS; HYPERTENSION; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; SODIUM CHLORIDE, DIETARY;

EID: 76349094648     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.197     Document Type: Article

References (55)

1. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med 1982; 306: 1276-1279.
2. Dustan H. Does keloid pathogenesis hold the key to understanding Black/White differences in hypertension severity? Hypertension 1995; 26: 858-862.
3. McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 1988; 12: 285-290.
4. Cardillo C, Kilcoyne CM, Cannon 3rd RO, Panza JA. Attenuation of cyclic nucleo-tide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. Circulation 1999; 99: 90-95.
5. Jones DW, Chambless LE, Folsom AR, Heiss G, Hutchinson RG, Sharrett AR, Szklo M, Taylor Jr HA. Risk factors for coronary heart disease in African Americans: the atherosclerosis risk in communities study, 1987-1997. Arch Intern Med 2002; 162: 2565-2571.
6. Stein CM, Lang CC, Nelson R, Brown M, Wood AJ. Vasodilation in black Americans: attenuated nitric oxide-mediated responses. Clin Pharmacol Ther 1997; 62: 436-443. (Pubitemid 27475228)
7. Nakayama T, Sato W, Kosugi T, Zhang L, Campbell-Thompson M, Yoshimura A, Croker BP, Johnson RJ, Nakagawa T. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am J Physiol Renal Physiol 2009; 296: F317-F327.
8. Stafford-Smith M, Podgoreanu M, Swaminathan M, Phillips-Bute B, Mathew JP, Hauser EH, Winn MP, Milano C, Nielsen DM, Smith M, Morris R, Newman MF, Schwinn DA. Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. Am J Kidney Dis 2005; 45: 519-530.
9. Campese VM, Parise M, Karubian F, Bigazzi R. Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 1991; 18: 805-812.
10. Frohlich ED, Messerli FH, Dunn FG, Oigman W, Ventura HO, Sundgaard-Riise K. Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab 1984; 10: 173-177.
11. Obialo CI, Hewan-Lowe K. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria. J Natl Med Assoc 1998; 90: 649-655.
12. Trolliet MR, Rudd MA, Loscalzo J. Oxidative stress and renal dysfunction in salt-sensitive hypertension. Kidney Blood Press Res 2001; 24: 116-123.
13. Boero R, Pignataro A, Quarello F. Salt intake and kidney disease. J Nephrol 2002; 15: 225-229.
14. Jones-Burton C, Mishra SI, Fink JC, Brown J, Gossa W, Bakris GL, Weir MR. An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease. Am J Nephrol 2006; 26: 268-275.
15. Li J, White J, Guo L, Zhao X, Wang J, Smart EJ, Li XA. Salt inactivates endothelial nitric oxide synthase in endothelial cells. J Nutr 2009; 139: 447-451.
16. Campese VM, Mozayeni P, Ye S, Gumbard M. High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure. J Nephrol 2002; 15: 407-413.
17. Benter IF, Yousif MH, Anim JT, Cojocel C, Diz DI. Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Am J Physiol Heart Circ Physiol 2006; 290: H684-H691.
18. Fujihara CK, Sena CR, Malheiros DM, Mattar AL, Zatz R. Short-term nitric oxide inhibition induces progressive nephropathy after regression of initial renal injury. Am J Physiol Renal Physiol 2006; 290: F632-F640.
19. Leonard AM, Chafe LL, Montani JP, Van Vliet BN. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice. Am J Hypertens 2006; 19: 1264-1269.
20. Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991; 88: 1559-1567.
21. Simchon S, Manger W, Blumberg G, Brensilver J, Cortell S. Impaired renal vasodila-tion and urinary cGMP excretion in Dahl salt-sensitive rats. Hypertension 1996; 27: 653-657.
22. Rudd MA, Trolliet M, Hope S, Scribner AW, Daumerie G, Toolan G, Cloutier T, Loscalzo J. Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOS II inhibition. Am J Physiol 1999; 277: H732-H739.
23. Mattson DL, Higgins DJ. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension 1996; 27: 688-692.
24. Majid DS, Kopkan L. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol 2007; 34: 946-952.
25. Cardillo C, Kilcoyne CM, Cannon 3rd RO, Panza JA. Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation. Hypertension 1998; 31: 1235-1239.
26. Shulman N, Ford C, Hall W, Blaufox M, Simon D, Langford H, Schneider K. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-up Program. Hypertension 1989; 13(Suppl I): I80-I93.
27. Jones DS, Andrawis NS, Abernethy DR. Impaired endothelial-dependent forearm vascular relaxation in black Americans. Clin Pharmacol Ther 1999; 65: 408-412.
28. Weinberger MH, Miller JZ, Luft FC, Grim CE, Finberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8: II-127-II-134.
29. Marcantoni C, Ma LJ, Federspiel C, Fogo AB. Hypertensive nephrosclerosis in African Americans versus Caucasians. Kidney Int 2002; 62: 172-180.
30. Pat B, Hughson MD, Nicol JL, Hoy WE, Gobe GC. A comparison of pathomolecular markers of fibrosis and morphology in kidney from autopsies of African Americans and whites. Virchows Arch 2007; 450: 41-50.
31. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-242.
32. Forbes MS, Thornhill BA, Park MH, Chevalier RL. Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury. Am J Pathol 2007; 170: 87-99.
33. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007; 18: 539-550.
34. Vaskonen T, Mervaala E, Krogerus L, Teravainen TL, Laakso J, Karppanen H, Vapaatalo H. Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats. Hypertens Res 1997; 20: 183-192.
35. Hartner A, Cordasic N, Klanke B, Veelken R, Hilgers KF. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice. Nephrol Dial Transplant 2003; 18: 1999-2004.
36. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996; 93: 13176-13181.
37. Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992; 20: 298-303.
38. Raij L. Nitric oxide in hypertension. Relationship with renal injury and left ventricular hypertrophy. Hypertension 1998; 31: 189-193.
39. Godecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Godecke S, Schrader J. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 1998; 82: 186-194.
40. Bubikat A, De Windt LJ, Zetsche B, Fabritz L, Sickler H, Eckardt D, Godecke A, Baba HA, Kuhn M. Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice. J Biol Chem 2005; 280: 21594-21599.
41. Yang XP, Liu YH, Shesely EG, Bulagannawar M, Liu F, Carretero OA. Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury. Hypertension 1999; 34: 24-30.
42. Mervaala EM, Laakso J, Vapaatalo H, Karppanen H. Effects of enalapril and hydro-chlorothiazide on the salt-induced cardiac and renal hypertrophy in normotensive rats. Naunyn Schmiedebergs Arch Pharmacol 1994; 350: 416-425.
43. Antonios TF, MacGregor GA. Salt intake. potential deleterious effects excluding blood pressure. J Hum Hypertens 1995; 9: 511-515.
44. Coca A, De la Sierra A. Salt sensitivity and left ventricular hypertrophy. Adv Exp Med Biol 1997; 432: 91-101.
45. Weir MR. Salt intake and hypertensive renal injury in African-Americans. A therapeutic perspective. Am J Hypertens 1995; 8: 635-644.
46. Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998; 98: 2621-2628.
47. Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 1994; 23: 531-550.
48. Yuan BX, Leenen FH. Dietary sodium intake and left ventricular hypertrophy in normotensive rats. Am J Physiol 1991; 261: H1397-H1401.
49. Frohlich ED, Chien Y, Sesoko S, Pegram BL. Relationship between dietary sodium intake, hemodynamics, and cardiac mass in SHR and WKY rats. Am J Physiol 1993; 264: R30-R34.
50. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 1988; 78: 951-956.
51. Herrera M, Garvin JL. A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1. Am J Physiol Renal Physiol 2005; 288: F58-F64.
52. Hirai T, Okumura K, Nishimoto Y, Shumiya T, Murakami R, Takahashi R, Asai T, Murakami H, Numaguchi Y, Matsui H, Murohara T. Upregulation of renal eNOS by high-sodium diet facilitates hypertension in doxorubicin-treated rats through enhanced oxidative stress. Toxicology 2006; 225: 81-89.
53. Ni Z, Vaziri ND. Effect of salt loading on nitric oxide synthase expression in normo-tensive rats. Am J Hypertens 2001; 14: 155-163. (Pubitemid 32171568)
54. Radin MJ, Holycross BJ, Hoepf TM, McCune SA. Salt-induced cardiac hypertrophy is independent of blood pressure and endothelin in obese, heart failure-prone SHHF rats. Clin Exp Hypertens 2008; 30: 541-552.
55. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning Jr RD. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 2005; 45: 934-939.